Noveris Health Sciences Inc. (NVRS.CN)
Develops medicines to treat nicotine addiction and PTSD using novel compounds
1.21-0.09%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+142.0%
The outlook
Noveris Health Sciences is trading near the lower end of its 52-week range at $1.21, with a mixed price trend against key moving averages. Analyst coverage appears limited, and the stock carries a neutral overall outlook based on current market data.
What’s behind the score
Price trendMixed vs its moving averages
52-week range38% of the way from its 52-week low to high
Market cap
$70.8M
52-wk high
3.00
52-wk low
0.12
50-day avg
1.78
200-day avg
1.00
Trailing P/E
0.5